| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/24/2003 | WO2003018612A3 Extracellular messengers |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | WO2002059323A3 Aminoacyl trna synthetases |
| 07/24/2003 | WO2002005858A3 Fluorescent agents for real-time measurement of organ function |
| 07/24/2003 | US20030139586 C3' -methylene hydrogen phosphonate oligomers and related compounds |
| 07/24/2003 | US20030139466 Autoimmune diseases; administering a photoactive material to blood |
| 07/24/2003 | US20030139357 Adjustment, compression of nervous systems; detection, monitoring variations in pain |
| 07/24/2003 | US20030139346 Polymer stabilized neuropeptides |
| 07/24/2003 | US20030138380 Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients |
| 07/24/2003 | US20030138379 Methods for treating urinary incontinence in mammals |
| 07/24/2003 | US20030138378 Method and apparatus for examining tissue for predefined target cells, particularly cancerous cells, and a probe useful in such method and apparatus |
| 07/24/2003 | US20030138375 Individualization of therapy with Alzheimer's disease agents |
| 07/24/2003 | CA2464472A1 Antibody targeting compounds |
| 07/23/2003 | EP1329227A1 Diagnostic conjugate useful for intercellular imaging and for differentiating between tumor- and non-tumor cells |
| 07/23/2003 | EP1328635A2 Compositions and methods relating to lung specific genes |
| 07/23/2003 | EP1328630A2 Secreted proteins |
| 07/23/2003 | EP1128784B1 Therapeutic use of polymers |
| 07/23/2003 | EP0748444B1 Method of monitoring patient compliance with medications prescriptions |
| 07/23/2003 | EP0625910B1 Dual carrier immunogenic construct |
| 07/23/2003 | CN1431041A Granular body contg. polydroxy alkoxide acid ester |
| 07/22/2003 | US6596924 Mouse grafted with human foreskin tissue; inducing and sustaining growth of the virus; useful for drug testing |
| 07/22/2003 | US6596259 Iron pyrazole complex; electron transfer core encapsulated in protective shell; magnetic resonance imaging contrast agent; varying solubility by outer shell substitution |
| 07/22/2003 | US6596258 Administering isotope containing imidazole compound; higher sensitivity |
| 07/22/2003 | US6596257 In situ labeling of preferential tissues; obtain tissue, incubate with conjugate, monitor sample for visible signal |
| 07/22/2003 | US6596206 Generation of pharmaceutical agent particles using focused acoustic energy |
| 07/22/2003 | US6595925 Diagnostic ultrasound imaging; prolonging the useful imaging time window |
| 07/22/2003 | CA2083041C Labeled compounds for use in a diagnostic breath test |
| 07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | WO2003057259A2 Indocyanine green (icg) compositions |
| 07/17/2003 | WO2003057155A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 07/17/2003 | WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | WO2003057007A2 System for monitoring bacterial tumor treatment |
| 07/17/2003 | WO2002059286A3 Adenylate cyclases |
| 07/17/2003 | WO2002026998A3 Hydrolases |
| 07/17/2003 | US20030135869 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds |
| 07/17/2003 | US20030135108 High throughput screening methods using magnetic resonance imaging agents |
| 07/17/2003 | US20030134826 Cell surface binding group or a cell recognising group, and also by a bio-active group, the bio- active group attached to a carbonyl of the cross-linker by an acid labile bond. Examples of suitable bio-active groups including |
| 07/17/2003 | US20030134339 Proteomics based method for toxicology testing |
| 07/17/2003 | US20030134032 Delivering solid article comprising an initiator to intended site of formation of hydrogel and delivering gellable composition that will form a hydrogel; embolic agents |
| 07/17/2003 | US20030133985 Controlled release oral dosage forms; data obtained using disintegration test such as the established USP Disintegration Test, rather than the results obtained using a standard USP Dissolution Test, as is conventionally done |
| 07/17/2003 | US20030133972 Macromolecules of 3-(4-(2-(3,4,5,6-tetrahydropyrimidin-2-ylamino)-ethyloxy)-benzoylamino)-2(S)-benzene-sulfonyl -aminopropionic acid moiety |
| 07/17/2003 | US20030133955 Methods and compositions useful for administration of chemotherapeutic agents |
| 07/17/2003 | US20030133914 Method for suppressing immune system response to transplanted tissue or cells |
| 07/17/2003 | US20030133876 Preparation of further diagnostic agents |
| 07/17/2003 | US20030133872 Radiopharmaceutical agent for the treatment of early stage cancer |
| 07/17/2003 | CA2472383A1 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2470411A1 System for monitoring bacterial tumor treatment |
| 07/17/2003 | CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/16/2003 | EP1326863A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 07/16/2003 | EP1326651A2 Dynamic organ function monitoring agents |
| 07/16/2003 | EP1326650A2 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
| 07/16/2003 | EP1326649A1 Tissue-specific exogenous optical agents |
| 07/16/2003 | EP1326648A1 Novel dyes for organ function monitoring |
| 07/16/2003 | EP1326647A1 Light sensitive compounds for instant determination of organ function |
| 07/16/2003 | EP1326602A1 Indole compounds as minimally physiologial function monitioring agents |
| 07/16/2003 | EP1210353B1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 07/16/2003 | EP1191947A4 Methods for treating avm' using radioactive compositions |
| 07/16/2003 | EP1180043B1 Multi-stage method for producing gas-filled microcapsules |
| 07/16/2003 | EP0781145B1 Diagnostic compositions and their use for the detection of central nervous system abnormalities |
| 07/16/2003 | CN1430505A Microspheres for active embolization |
| 07/16/2003 | CN1429626A Upper digestive tract cancer primary screening general investigation test solution |
| 07/15/2003 | US6593334 Camptothecin-taxoid conjugates as antimitotic and antitumor agents |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593144 Detecting a spatial distribution of at least one noble gas by nuclear magnetic resonance spectrometry and generating a representation of spatial distribution of the noble gas preferably xenone-129 and/or helium -3 |
| 07/15/2003 | US6593094 Compositions to enhance the efficacy and safety of bio-pharmaceutical drugs |
| 07/15/2003 | US6592877 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592847 Intramolecularly-quenched near infrared flourescent probes |
| 07/15/2003 | US6592846 Preventing collapse under pressure by filling with water insoluble perhalocarbon gas |
| 07/15/2003 | CA2128942C Process for the crystallization of iopamidol |
| 07/10/2003 | WO2003056012A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | WO2003055379A2 Method using a surface-selective nonlinear optical technique for imaging of biological samples |
| 07/10/2003 | WO2003037298A3 Bowel cleansing agent |
| 07/10/2003 | WO2002079778A3 In vivo delivery methods and compositions |
| 07/10/2003 | WO2002066264A3 Tatoo method and system for medical and surgical applications |
| 07/10/2003 | WO2002057417A3 Angiogenesis gene and modulators |
| 07/10/2003 | US20030131367 Kv3.3b potassium channel disruptions, compositions and methods related thereto |
| 07/10/2003 | US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof |
| 07/10/2003 | US20030129579 Multi-use multimodal imaging chelates |
| 07/10/2003 | US20030129223 Therapeutic agents, comprising a linking carrier, a therapeutic entity associated with the linking carrier, and atleast one targeting entity |
| 07/10/2003 | US20030129137 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 07/10/2003 | US20030129136 Complexing; binding epitopes to surfaces; imaging; detection thrombosis, infections, cancer; acoustic reflection |
| 07/10/2003 | US20030129135 Magnetic resonance imaging; measuring blood flow |
| 07/10/2003 | US20030129133 PACAP compositions and methods for tumor imaging and therapy |
| 07/10/2003 | US20030129130 Drug delivery; microparticles immobilized on polymer surface |
| 07/10/2003 | CA2470903A1 A system for stable expression of sirnas in mammalian cells |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 07/09/2003 | CN1429089A Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging |
| 07/09/2003 | CN1429086A Diagnostic procedures using direct injection of gaseous hyperpolarized 129Xe and associated systems and products |
| 07/09/2003 | CN1113882C Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 07/08/2003 | US6589998 Administering biocompatible polymer in solvent |
| 07/08/2003 | US6589506 Administering noble gas by breathing; injecting contrast agent |
| 07/08/2003 | US6589505 Cells that lack p19ink4d and p27kip1 activity and methods of use thereof |
| 07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 07/08/2003 | CA2095615C Polyazamacrocyclic compounds for complexation of metal ions |
| 07/03/2003 | WO2003053488A1 A new bone mineral substitute |
| 07/03/2003 | WO2003029488A3 A method for the early detection of cancer |
| 07/03/2003 | WO2003011215A3 Method and system to determine revised dosage |